Attached files

file filename
8-K - FORM 8-K - MOCON INCmoco20151105_8k.htm
EX-99.2 - EXHIBIT 99.2 - MOCON INCex99-2.htm

Exhibit 99.1

 

 

FOR IMMEDIATE RELEASE

For More Information Contact:
    Elissa Lindsoe, CFO

November 5, 2015

 

763-493-6370 /

www.mocon.com

 

MOCON Reports Third Quarter Results; Announces Corporate Realignment Plan

 

Highlights:

 

 

Overall Revenue increased 5 percent on a Constant Currency basis

 

Approximately $1.7 million of pre-tax savings in 2016 from realignment plan

 

Double digit growth in Permeation and Package Testing Segments on a Constant Currency basis

 

 

MINNEAPOLIS, MN, November 5, 2015MOCON, Inc. (NASDAQ: MOCO), today reported financial results for the third quarter ended September 30, 2015.

 

Commenting on the Company’s performance, MOCON’s president and CEO, Robert L. Demorest said, “On a Constant Currency basis, our third quarter revenue grew 5 percent. Our Permeation and Package Testing business segments both continue to meet our growth expectations at 18 percent and 10 percent respectively. As experienced in the first half of the year, our Industrial Analyzer and Other segment continues to be challenged by the soft oil and gas market. Our earnings are trending up; on a sequential basis diluted EPS improved by 82 percent as revenue improved while we prudently managed costs and expenses. While the strengthening of the US dollar negatively impacted our revenue as reported for the three and nine-month periods, there is less of an effect to our operating income. A large portion of the costs to support our international businesses are denominated in foreign currencies, which provides a natural hedge therefore mitigating the negative effect of a strengthening dollar to operating profits.

 

“As part of an ongoing process improvement initiative designed to grow MOCON’s global brand and to provide our customers with enhanced products and services, we recently implemented a realignment plan and as part of that plan, we brought the sales and marketing functions of our Package Testing and Permeation business segments under common leadership. Overall, the realignment resulted in a 5 percent reduction in our U.S. headcount. We expect the realignment plan, which also includes the elimination of several vacant positions within other areas of the Company, will result in approximately $1.7 million of pre-tax savings in 2016. We will record a pre-tax charge of approximately $0.5 million, or $0.09 per diluted share, in the fourth quarter of 2015 related to employee separation costs. We believe the decision to have common leadership over both of these businesses will not only strengthen our market presence, but will also provide a cost-effective approach to achieving our objectives”.

 

 
 

 

 

2015 Revenue and Earnings Summary

 

Third quarter 2015 results compared to third quarter 2014:

 

Reported revenue decreased 7 percent as compared to the third quarter 2014. On a Constant Currency basis, revenue increased 5 percent compared to the year ago quarter.

 

Revenue (as reported) from foreign customers accounted for 62 percent (40 percent in Europe, 22 percent outside of Europe & the U.S.A.) of total revenue for the third quarter of 2015 compared to 67 percent (41 percent in Europe, 26 percent outside of Europe & the U.S.A.) in the third quarter of 2014.

 

Net income was $1.2 million, or $0.20 per diluted share, compared to $1.7 million, or $0.29 per diluted share in the year ago quarter.

 

Adjusted EBITDA for third quarter of 2015 was $2.6 million compared to $3.3 million in the third quarter of 2014. (See reconciliation to non-GAAP information below).

 

 

Nine months ended September 30, 2015 results compared to the year ago nine month period:

 

Reported revenue decreased 3 percent as compared to the year ago period. On a Constant Currency basis, revenue increased 6 percent compared to the year ago nine month period.

 

Revenue (as reported) from foreign customers accounted for 66 percent (38 percent in Europe, 28 percent outside of Europe & the U.S.A.) of total revenue for the nine month period of 2015 compared to 71 percent (42 percent in Europe, 29 percent outside of Europe & the U.S.A.) in the year ago period.

 

Net income was $2.7 million, or $0.46 per diluted share, compared to $3.6 million, or $0.62 per diluted share in the year ago period.

 

Adjusted EBITDA for the nine month period ended September 30, 2015 was $6.5 million compared to $7.7 million in the year ago nine month period.

 

Revenue by Segment ($ in thousands)

 

   

Three Months Ended September 30,

 
   

As Reported

   

Year over Year Growth

   

Currency impact on 2015 Growth

   

2015 Revenue at Constant

   

Year-over-Year Constant Currency

 
   

2015

   

2014

    $     

%

    $    

Currency

   

Growth %

 

Package Testing

  $ 6,454     $ 7,342     $ (888 )     -12 %   $ (1,643 )   $ 8,097       10 %

Permeation

    6,482       5,729       753       13 %     (276 )     6,758       18 %

Industrial Analyzers and Other

    2,556       3,578       (1,022 )     -29 %     -       2,556       -29 %

Total Revenue

  $ 15,492     $ 16,649     $ (1,157 )     -7 %   $ (1,919 )   $ 17,411       5 %

 

 

   

Nine Months Ended September 30,

 
   

As Reported

   

Year over Year Growth

   

Currency impact on 2015 Growth

   

2015 Revenue at Constant

   

Year-over-Year Constant Currency

 
   

2015

   

2014

       

%

    $     

Currency

   

Growth %

 

Package Testing

  $ 19,684     $ 21,320     $ (1,636 )     -8 %   $ (3,758 )   $ 23,442       10 %

Permeation

    18,550       16,622       1,928       12 %     (764 )     19,314       16 %

Industrial Analyzers and Other

    7,667       9,595       (1,928 )     -20 %     -       7,667       -20 %

Total Revenue

  $ 45,901     $ 47,537     $ (1,636 )     -3 %   $ (4,522 )   $ 50,423       6 %

 

 

Revenue from the Package Testing segment for both the three and nine months ended September 30, 2015 increased 10 percent on a Constant Currency basis due to an increase in headspace and mixer products and accessories. As reported, revenue decreased 12 percent and 8 percent, respectively, for the three and nine months ended September 30, 2015.

 

 
 

 

 

Revenue growth for the Permeation segment for the three months and nine months ended September 30, 2015 was 18 percent and 16 percent, respectively, on a Constant Currency basis and 13 percent and 12 percent, respectively, as reported. The current year growth is attributable to the continued increase in demand in the USA for the new generation of oxygen and water vapor permeation instrumentation, which was introduced to the marketplace during the second half of 2014.

 

Representing the smallest portion of MOCON’s reported revenue, currently 16 percent and only 22 percent at its peak, our Industrial Analyzer and Other segment declined 29 percent and 20 percent year-over-year for the three and nine months ended September 30, 2015. This was attributable to a 70 percent and 75 percent decline, respectively, in revenue from the oil and gas market. This decline is offset in part by increases in other markets including sales of environmental monitoring products and the sale of sensors into OEM partners.

 

Gross Profit, Operating Expenses and Other Income Commentary

 

Gross profit was 54 percent of revenue for each of the three and nine month periods ended September 30, 2015, respectively, compared to 57 percent and 56 percent of revenue for the same periods in 2014, respectively. The decrease in the gross margin rate is driven primarily by reduced revenue volume in Industrial Analyzer and Other segment which provides a lower basis to absorb semi-variable and fixed production costs, production ramp up costs associated with the recently introduced next generation Permeation products, and increased cost for products produced in the USA that are sold in euros. The overall decline was partially offset by increased production and efficiencies for products produced internationally.

 

Selling, general and administrative expenses were slightly lower during the third quarter and first nine months of 2015 compared to the same periods in 2014 due primarily to favorable foreign exchange rates partially offset by the cost of the Company’s legal entity realignment initiative of $190,000 and $318,000 in each of the quarter and year-to-date periods ending September 2015. Research and development expenses remained consistent at 6-8% of revenue for all periods.

 

Balance Sheet and Cash Flow Summary

 

 

Cash and cash equivalents increased slightly to $6.4 million at September 30, 2015 compared to $6.3 million at December 31, 2014.

 

Net cash provided by operations was $4.4 million compared to $6.4 million in the first nine months of 2014 primarily driven by the change in net income and a $2.3 million decline in accounts payable and accrued compensation offset by a $1.5 million reduction in inventory.

 

Days sales outstanding were 51 days, a 6 day improvement from 57 in the third quarter of 2014 driven by an increased focus on collections.

 

Total debt was $3.7 million at September 30, 2015, a $0.9 million reduction when compared to $4.6 million at December 31, 2014.

 

 

About MOCON

 

MOCON is a leading provider of detectors, instruments, systems and consulting services to research laboratories, production facilities, and quality control and safety departments in the medical, pharmaceutical, food and beverage, packaging, environmental, oil and gas and other industries worldwide. See www.mocon.com for more information.

 

 
 

 

 

Use of Non-GAAP Financial Measures

 

MOCON’s management evaluates its financial results on a constant currency basis which is calculated by adjusting the current period reported revenue to the comparative period’s currency translation rate (“Constant Currency”) and believes that investors may want to consider this impact on the Company’s performance. In addition, MOCON supplements its financial statements to provide investors with earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA plus share-based compensation, legal entity realignment expenses and foreign currency transactional losses (“Adjusted EBITDA”), which are not calculated in accordance with general accepted accounting principles (“GAAP”) in the United States of America.

 

MOCON believes that these non-GAAP measures provide useful information to the Company’s Board of Directors, management and investors regarding certain trends relating to its financial condition and operating performance. MOCON’s management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses and planning purposes. In addition, revenue on a Constant Currency basis is used to assess the revenue growth component of MOCON’s Incentive Pay Plan.

 

The method MOCON uses to produce non-GAAP results is not computed according to GAAP, is likely to differ from the methods used by other companies and should not be regarded as a replacement for corresponding GAAP measures. MOCON urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures that are included in this press release.

 

Safe Harbor

 

This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements that can be identified by words such as “will,” “may,” “expect,” “believe,” “anticipate,” “estimate,” “continue,” “planned”, or other similar expressions. All forward-looking statements speak only as of the date of this press release. MOCON undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. In addition to the risks and uncertainties of ordinary business operations and conditions in the general economy and the markets in which the Company competes, there are important factors that could cause actual results to differ materially from those anticipated by the forward-looking statements made in this press release. These factors include, but are not limited to, the performance of Dansensor, worldwide economic conditions and fluctuations in foreign currency exchange rates, the terms of our credit agreement including financial covenants included therein, dependence on certain key industries, pricing and lack of availability of raw materials, crude oil pricing impact on oil exploration activities, and other factors set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014 and other documents MOCON files with or furnishes to the Securities and Exchange Commission.

 

MOCON's shares are traded on the NASDAQ Global Market System under the symbol MOCO.

MOCON is a registered trademark of MOCON, Inc.; other trademarks are those of their respective holders.

 

 
 

 

 

MOCON, INC.

SUMMARY CONSOLIDATED FINANCIAL DATA

(in Thousands, Except Per Share Data)

        

STATEMENT OF OPERATIONS DATA: (unaudited)       

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2015

   

2014

   

2015

   

2014

 

Revenue

                               

Products

  $ 12,241     $ 13,110     $ 36,442     $ 37,384  

Services

    2,496       2,745       7,338       7,983  

Consulting

    755       794       2,121       2,170  

Total revenue

    15,492       16,649       45,901       47,537  

Cost of revenue

                               

Products

    5,707       5,648       16,490       16,318  

Services

    1,010       992       3,074       3,133  

Consulting

    457       447       1,515       1,412  

Total cost of revenue

    7,174       7,087       21,079       20,863  

Gross profit

    8,318       9,562       24,822       26,674  
                                 

Selling, general and administrative expenses

    5,808       6,125       17,914       18,216  

Research and development expenses

    886       950       3,081       3,064  

Operating income

    1,624       2,487       3,827       5,394  

Other income (expense), net

    (48 )     (117 )     90       (267 )
                                 

Income before income taxes

    1,576       2,370       3,917       5,127  
                                 

Income tax expense

    424       696       1,211       1,558  
                                 

Net income

  $ 1,152     $ 1,674     $ 2,706     $ 3,569  
                                 

Net income per common share:

                               

Basic

  $ 0.20     $ 0.30     $ 0.47     $ 0.63  

Diluted

  $ 0.20     $ 0.29     $ 0.46     $ 0.62  

Weighted average common shares outstanding:

                               

Basic

    5,753       5,668       5,748       5,655  

Diluted

    5,808       5,776       5,826       5,768  

 

 

 

CONDENSED BALANCE SHEET DATA: (unaudited)        

 

   

September 30, 2015

   

December 31, 2014

 

Assets:

               

Cash and cash equivalents

  $ 6,413     $ 6,332  

Accounts receivable, net

    8,710       9,877  

Inventories

    8,390       8,705  

Other current assets

    2,829       2,587  

Total current assets

    26,342       27,501  

Property, plant and equipment, net

    6,028       5,562  

Goodwill, intangibles and other assets

    17,172       19,446  

Total assets

  $ 49,542     $ 52,509  

Liabilities and Shareholders’ Equity:

               

Revolving lines of credit

  $ ---     $ 3,300  

Notes payable, current

    64       983  

Other current liabilities

    9,973       11,166  

Total noncurrent liabilities

    5,708       2,587  

Shareholders’ equity

    33,797       34,473  

Total liabilities and shareholders’ equity

  $ 49,542     $ 52,509  

 

 
 

 

CONDENSED CASH FLOW DATA: (unaudited)

 

September 30, 2015

   

September 30, 2014

 
                 

Net cash provided by operations

  $ 4,417     $ 6,430  

Net cash used in investing activities

    (1,144 )     (1,113 )

Net cash used in financing activities

    (2,816 )     (2,965 )

Effect of exchange rate changes

    (376 )     (344 )

Net increase in cash

    81       2,008  

Cash beginning of period

    6,332       4,133  

Cash end of period

  $ 6,413     $ 6,141  

 

 

 

 

 MOCON, INC.

 NON-GAAP RECONCILIATION

 (in Thousands)

         

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2015

   

2014

   

2015

   

2014

 
                                 

Net income

  $ 1,152     $ 1,674     $ 2,706     $ 3,569  

Interest expense, net

    31       45       97       147  

Income tax expense

    424       696       1,211       1,557  

Depreciation and amortization

    614       656       1,834       1,924  

EBITDA

    2,221       3,071       5,848       7,197  

Share-based compensation

    167       129       488       413  

Legal entity realignment expenses

    190       ---       318       ---  

Foreign currency transaction loss (gain)

    17       72       (186 )     120  

Adjusted EBITDA

  $ 2,595     $ 3,272     $ 6,468     $ 7,730